Radical technological change and innovation are transforming the delivery of healthcare services in Asia Pacific.
Baker & McKenzie's report, Powering the Future of Healthcare in Asia Pacific, examines how this transformation is affecting the region's legal and regulatory landscape and, in turn, how laws and regulations in Asia Pacific impact advances in healthcare technology. It also looks at where the funding for this change is coming from.
The HealthTech Report has been developed in partnership with The Propell Group, a boutique venture investor and advisory firm focused on healthtech early-stage companies. The latest chapter on Data-driven Healthcare is now available for download on the App Store and is compatible with iPad devices. In this chapter, we will look into the legal implications of Big Data, the rise of Mobile Health and biosensing wearables, as well as data privacy and other regulatory challenges that healthtech companies face. Future chapters will discuss funding and other opportunities that healthtech presents.
#healthtechasia
Powering the Future of Healthcare in Asia | The Propell Group | Baker & McKenzieJulien de Salaberry
Ā
"Powering the Future of Healthcare in Asia Pacific" is a six-part report series produced by Baker & McKenzie in partnership with The Propell Group. The Report, which will be released over the period of six months, considers the impact of technological innovation on healthcare in the region and highlights some of the legal concerns which start-up innovators, and pharmaceutical and medical devices companies may face in this new paradigm of e-Health
#healthtechasia
This white paper has elicited views from a broad group of
industry parDcipants about the future of the Biosciences
industry in Singapore. It provides themes that can help to
guide the development of innovaDve ideas to propel the next
lap of Biosciences growth in Singapore.
Powering the Future of Healthcare in Asia Pacific | Funding, IP Protection | ...Julien de Salaberry
Ā
1) The document discusses how emerging technologies like big data, biosensors, mobile devices, and genomics are driving a revolution in healthcare delivery in Asia Pacific.
2) It argues that these technologies will enable a shift from disease-centric to prevention-centric healthcare by facilitating early detection, monitoring, and customized care.
3) However, the legal and regulatory landscape is lagging behind technological advances, raising issues around data privacy, medical device regulation, and intellectual property protection that will need to be addressed.
Kim Solez believes that as technology advances and diseases are eliminated, the role of physicians will change from healing the body to enhancing lives. Physicians will take on greater social responsibility for improving people physically, mentally, and spiritually. Medical school will also change to focus more on humanism beyond disease treatment and to educate both humans and machines. Doctors of the future will need to consider how to help transform society on a large scale through "medicine writ large."
Capital Raising for MedTech SMEs | MedTech Forum 2015 APAC | ApacMed | The Pr...Julien de Salaberry
Ā
Introduction to the global healthcare and Asia healthtech funding landscape. Briefing on the early stage venture funding journey and guidance on the approach to funding. Followed by a panel discussion from local experts.
#healthtechasia
Powering the Future of Healthcare in Asia Pacific | Full ReportGalen Growth
Ā
How technology will change healthcare delivery
1) The creative destruction of healthcare
2) Data driven healthcare
3) Funding
4) Disruption in Healthcare
5) Opportunity to leapfrog to accelerate change
Cyrcadia Health - Health & Wearable Singapore 2015 - The Propell GroupJulien de Salaberry
Ā
This document discusses a wearable breast cancer screening device called Cyrcadia Health. It is a bra insert that uses sensor technology and connects to the internet to detect metabolic changes associated with breast cancer. The device aims to enable early detection of breast cancer through improved screening compared to mammography. It also seeks to reduce unnecessary biopsies by over 80% and create a large database for breast cancer research through data collection from users. The company plans limited validation trials of the device in late 2015 through hospitals in Singapore and India, with an Asia commercial launch targeted for early 2016.
At Modern Health Talk, we see the future of mHealth as less about Mobile health and more about MODERN healthcare that includes all sorts of solutions for addressing demographic shift of retiring baby boomers and the resulting doctor shortage.
These solutions include mobile technologies (smartphones & tablets) and big broadband support of high-def video calls with medical imaging, as well as new delivery options such as retail clinics and insurance-funded home care (and home modifications), remote sensor monitoring, healthcare robots, Watson-like cloud services, new laws & regulations, support of family caregivers, and more.
Powering the Future of Healthcare in Asia | The Propell Group | Baker & McKenzieJulien de Salaberry
Ā
"Powering the Future of Healthcare in Asia Pacific" is a six-part report series produced by Baker & McKenzie in partnership with The Propell Group. The Report, which will be released over the period of six months, considers the impact of technological innovation on healthcare in the region and highlights some of the legal concerns which start-up innovators, and pharmaceutical and medical devices companies may face in this new paradigm of e-Health
#healthtechasia
This white paper has elicited views from a broad group of
industry parDcipants about the future of the Biosciences
industry in Singapore. It provides themes that can help to
guide the development of innovaDve ideas to propel the next
lap of Biosciences growth in Singapore.
Powering the Future of Healthcare in Asia Pacific | Funding, IP Protection | ...Julien de Salaberry
Ā
1) The document discusses how emerging technologies like big data, biosensors, mobile devices, and genomics are driving a revolution in healthcare delivery in Asia Pacific.
2) It argues that these technologies will enable a shift from disease-centric to prevention-centric healthcare by facilitating early detection, monitoring, and customized care.
3) However, the legal and regulatory landscape is lagging behind technological advances, raising issues around data privacy, medical device regulation, and intellectual property protection that will need to be addressed.
Kim Solez believes that as technology advances and diseases are eliminated, the role of physicians will change from healing the body to enhancing lives. Physicians will take on greater social responsibility for improving people physically, mentally, and spiritually. Medical school will also change to focus more on humanism beyond disease treatment and to educate both humans and machines. Doctors of the future will need to consider how to help transform society on a large scale through "medicine writ large."
Capital Raising for MedTech SMEs | MedTech Forum 2015 APAC | ApacMed | The Pr...Julien de Salaberry
Ā
Introduction to the global healthcare and Asia healthtech funding landscape. Briefing on the early stage venture funding journey and guidance on the approach to funding. Followed by a panel discussion from local experts.
#healthtechasia
Powering the Future of Healthcare in Asia Pacific | Full ReportGalen Growth
Ā
How technology will change healthcare delivery
1) The creative destruction of healthcare
2) Data driven healthcare
3) Funding
4) Disruption in Healthcare
5) Opportunity to leapfrog to accelerate change
Cyrcadia Health - Health & Wearable Singapore 2015 - The Propell GroupJulien de Salaberry
Ā
This document discusses a wearable breast cancer screening device called Cyrcadia Health. It is a bra insert that uses sensor technology and connects to the internet to detect metabolic changes associated with breast cancer. The device aims to enable early detection of breast cancer through improved screening compared to mammography. It also seeks to reduce unnecessary biopsies by over 80% and create a large database for breast cancer research through data collection from users. The company plans limited validation trials of the device in late 2015 through hospitals in Singapore and India, with an Asia commercial launch targeted for early 2016.
At Modern Health Talk, we see the future of mHealth as less about Mobile health and more about MODERN healthcare that includes all sorts of solutions for addressing demographic shift of retiring baby boomers and the resulting doctor shortage.
These solutions include mobile technologies (smartphones & tablets) and big broadband support of high-def video calls with medical imaging, as well as new delivery options such as retail clinics and insurance-funded home care (and home modifications), remote sensor monitoring, healthcare robots, Watson-like cloud services, new laws & regulations, support of family caregivers, and more.
The new era of mobile health ushered in by the wide adoption of ubiquitous computing and mobile communications has brought opportunities for governments and companies to rethink their concept of healthcare. Simultaneously, the worldwide urbanization process represents a formidable challenge and attracts attention toward cities that are expected to gather higher populations and provide citizens with services in an efficient and human manner. These two trends have led to the appearance of mobile health and smart cities. In this talk we introduce the new concept of smart health, which is the context-aware complement of mobile health within smart cities. We provide an overview of the main fields of knowledge that are involved in the process of building this new concept. Additionally, we discuss the main challenges and opportunities that s-Health would imply and provide a common ground for further research.
1. Medical technology provides substantial benefits to patients' quality of life, disability levels, and mortality rates compared to traditional treatments like drugs alone.
2. While medical technology increases direct health care costs, it also provides significant economic and productivity benefits to society by reducing time lost from work and increasing overall welfare.
3. Studies show that many medical technologies reduce overall lifetime health care costs and societal costs compared to traditional treatments due to better health outcomes and shorter hospital stays.
The document discusses innovation in medical technologies from 1816 to the present, highlighting key milestones and advances. It outlines challenges and opportunities for medical technology innovation, including shifting demand factors with aging populations and emerging economies, and new scientific opportunities in areas like genomics, nanotechnology, and convergence of disciplines. Continued innovation will be needed to deliver affordable healthcare solutions globally.
The 10 Most Trustworthy Healthcare and Life Science solution providersā project. In this project we are presenting you some of the prominent companies and healthcare solution providers, who have very skillfully integrated technology into their daily functioning, services and products.
The future of healthcare: when mobile disappearsMatteo Penzo
Ā
In todayās digital world, mobile devices are the powerful bridges between a connected ecosystem of healthcare professionals, caregivers and patients. New developments in big data, wearable sensors and the application of social layers are shifting an industry that used to focus on curing diseases to one that emphasizes health and wellness. But the mass adoption of connected healthcare will only happen when solutions are designed to be intuitive and technologies are forgotten. The future of healthcare will happen when mobile disappears into the background, placing the patient in the center and in control of their lives.
The Propell Group - ESSEC Business School - Digital Health InnovationJulien de Salaberry
Ā
- The document discusses a presentation on digital health and innovation in digital health.
- It provides an overview of key topics in digital health including big data, wearable sensors and devices, business models in healthcare, and funding trends.
- The presentation covers how these elements are transforming healthcare through precision medicine, remote monitoring, and new partnerships between technology companies and pharmaceutical companies.
The Extreme Future of Health Care 2014James Canton
Ā
Radical trends in health care and medicine will change business and society. This presentation fresh from Dr. James Canton's New Keynote Presentation and from his upcoming new book looks at the trends in biotech, synthetic biology, digital health, genomics, wellness and regenerative medicine that will shape the near future of our world and health. Find out what's next and how to prepare today. For more info see http://globalfuturist.com
Understanding the health data future - Deloitte Healthconnect, co-hosted by D...DayOne
Ā
In collaboration with Deloitte, we launched in 2020 the DayOne Health Data Scenario Project. Some 50 Experts coming together in three workshops for a total of more than 18 hours have identified 10 potential scenarios that will lead the way in creating a much-needed efficient and rewarding healthcare data ecosystem. We presented our results in an online joint event: āUnderstanding the health data future ā Deloitte Healthconnect, co-hosted by DayOneā
2018 has finally arrived, and healthcare companiesā executives from both small and big firms have hit the ground running. With technological artificial intelligence and new drugs in the industry, below are 6 healthcare predictions for 2018.
Future of Healthcare ā Leadership Challenges
Further to several additional expert workshops this year, we are delighted to share an updated global perspective on the future of healthcare. Produced in partnership with Duke Corporate Education (http://www.dukece.com), this adds new insights on the pivotal shifts taking place across the sector plus viewpoints on some of the core implications for leadership. Topics include the growing power of data; the rising impact of urbanisation on health; increasing patient centricity; the need for more flexible organisations and the move of innovation activity eastwards.
Available as both this report and as an accompanying presentation (https://www.slideshare.net/futureagenda2/future-of-healthcare-15-october-2019-182433390) this is now being used to inform and provoke further debate around the world. As ever we would like to thank all those who have given their time and insight to contribute to this project.
Held each year in Boston, Medical Informatics World connects more than 400 healthcare, biomedical science, health informatics, and IT leaders to navigate emerging trends and opportunities in the evolving industry. The event responds to the challenges in collaborating and maximizing the benefit of enabling technologies with inspiring plenary keynotes combined with focused expert-led presentations and discussions. Coverage includes population health management, predictive analytics, payer-provider-pharma data collaborations, patient care and engagement, mobile and wearable technologies, care delivery models, enterprise hospital information systems, clinical decision support, error and readmission reduction, and healthcare data security. The 2015 program features six conference tracks, two interactive dinner workshops and six plenary keynote presentations, providing attendees with the connections, tools and strategies for taking their research and care delivery to the next level. Learn more at http://www.medicalinformaticsworld.com
Top 10 fastest growing healthcare tech companies 2021insightscare
Ā
The document discusses Claimocity, an AI-driven healthcare technology company that provides mobile practice management software. It highlights some key points:
- Claimocity aims to streamline administrative and billing processes for doctors to allow them to focus on patient care.
- Their all-in-one software and services solution reduces multiple vendors and systems into a single integrated platform.
- Their progress note generator feature combines clinical documentation and billing documentation into a single mobile workflow.
- CEO Jim Sholeff has played a key role in the company's success through his leadership, product development expertise, and focus on specialized solutions for specific customer needs.
Value-based Healthcare - Towards a systems approach in chronic diseasesnDayOne
Ā
Role of patient journey in science, predictive modeling and high-risk patients in early stages of disease progression, in real world context. Presented by Michael Rebhan, Novartis at the DayOne Basel event in June 2020
Trends in Digital Health and why you should careMichael Weber
Ā
Driven by demographic change, rising costs in the healthcare system and growing customer demands for patient-centered tools, the relevance of innovative Digital Health solutions is constantly growing. While many technologies are available on the market, there is still a lack of comprehensive solutions that support the patient across all his medical conditions and provide an integrated user experience throughout the patient's everyday life. Future Digital Health solutions will not only have to cross-link patient data across different devices and applications in order to enable better medical decisions, but also to create user experiences that address the patients' needs and help them to establish self-sustaining behaviors towards a healthier lifestyle.
Evolution of the healthcare industry in India and the potential impact of the...Harshit Jain
Ā
2014 looks to be a positive but challenging year for the Indian health care sector; one in which many historic business models and operating processes will no longer suffice amid rising demand, continued cost pressures, lack of or inadequate care facilities, and rapidly evolving market conditions. India, likely will be dominated by the āModi-careā āHealth assurance for all.
UAEās 10 Best Healthcare Service Providers 2021 July 2021.insightscare
Ā
UAEās 10 Best Healthcare Service Providers 2021 features a few healthcare service providers that have been at the forefront of UAEās health care system.
El documento presenta una serie de juegos y ejercicios para evaluar la agilidad mental. Incluye actividades como encontrar letras escondidas, resolver problemas lĆ³gicos, contar elementos en un texto y determinar cuĆ”l de varias opciones es diferente. El objetivo es entretener al lector mientras pone a prueba su capacidad de razonamiento y percepciĆ³n.
This document provides an overview of the emerging Direct Primary Care (DPC) medical practice model. DPC charges monthly fees directly to patients, rather than billing insurance, in exchange for primary care services. The history of DPC is traced back to the late 1990s when some practices in Seattle began adopting this model. Key principles of DPC include a direct financial relationship with patients, increased time with providers, accessibility, and avoiding incentives of fee-for-service billing. The document examines several early DPC organizations, regulatory issues, perspectives of payers and consumers, and how technology supports the DPC model.
The new era of mobile health ushered in by the wide adoption of ubiquitous computing and mobile communications has brought opportunities for governments and companies to rethink their concept of healthcare. Simultaneously, the worldwide urbanization process represents a formidable challenge and attracts attention toward cities that are expected to gather higher populations and provide citizens with services in an efficient and human manner. These two trends have led to the appearance of mobile health and smart cities. In this talk we introduce the new concept of smart health, which is the context-aware complement of mobile health within smart cities. We provide an overview of the main fields of knowledge that are involved in the process of building this new concept. Additionally, we discuss the main challenges and opportunities that s-Health would imply and provide a common ground for further research.
1. Medical technology provides substantial benefits to patients' quality of life, disability levels, and mortality rates compared to traditional treatments like drugs alone.
2. While medical technology increases direct health care costs, it also provides significant economic and productivity benefits to society by reducing time lost from work and increasing overall welfare.
3. Studies show that many medical technologies reduce overall lifetime health care costs and societal costs compared to traditional treatments due to better health outcomes and shorter hospital stays.
The document discusses innovation in medical technologies from 1816 to the present, highlighting key milestones and advances. It outlines challenges and opportunities for medical technology innovation, including shifting demand factors with aging populations and emerging economies, and new scientific opportunities in areas like genomics, nanotechnology, and convergence of disciplines. Continued innovation will be needed to deliver affordable healthcare solutions globally.
The 10 Most Trustworthy Healthcare and Life Science solution providersā project. In this project we are presenting you some of the prominent companies and healthcare solution providers, who have very skillfully integrated technology into their daily functioning, services and products.
The future of healthcare: when mobile disappearsMatteo Penzo
Ā
In todayās digital world, mobile devices are the powerful bridges between a connected ecosystem of healthcare professionals, caregivers and patients. New developments in big data, wearable sensors and the application of social layers are shifting an industry that used to focus on curing diseases to one that emphasizes health and wellness. But the mass adoption of connected healthcare will only happen when solutions are designed to be intuitive and technologies are forgotten. The future of healthcare will happen when mobile disappears into the background, placing the patient in the center and in control of their lives.
The Propell Group - ESSEC Business School - Digital Health InnovationJulien de Salaberry
Ā
- The document discusses a presentation on digital health and innovation in digital health.
- It provides an overview of key topics in digital health including big data, wearable sensors and devices, business models in healthcare, and funding trends.
- The presentation covers how these elements are transforming healthcare through precision medicine, remote monitoring, and new partnerships between technology companies and pharmaceutical companies.
The Extreme Future of Health Care 2014James Canton
Ā
Radical trends in health care and medicine will change business and society. This presentation fresh from Dr. James Canton's New Keynote Presentation and from his upcoming new book looks at the trends in biotech, synthetic biology, digital health, genomics, wellness and regenerative medicine that will shape the near future of our world and health. Find out what's next and how to prepare today. For more info see http://globalfuturist.com
Understanding the health data future - Deloitte Healthconnect, co-hosted by D...DayOne
Ā
In collaboration with Deloitte, we launched in 2020 the DayOne Health Data Scenario Project. Some 50 Experts coming together in three workshops for a total of more than 18 hours have identified 10 potential scenarios that will lead the way in creating a much-needed efficient and rewarding healthcare data ecosystem. We presented our results in an online joint event: āUnderstanding the health data future ā Deloitte Healthconnect, co-hosted by DayOneā
2018 has finally arrived, and healthcare companiesā executives from both small and big firms have hit the ground running. With technological artificial intelligence and new drugs in the industry, below are 6 healthcare predictions for 2018.
Future of Healthcare ā Leadership Challenges
Further to several additional expert workshops this year, we are delighted to share an updated global perspective on the future of healthcare. Produced in partnership with Duke Corporate Education (http://www.dukece.com), this adds new insights on the pivotal shifts taking place across the sector plus viewpoints on some of the core implications for leadership. Topics include the growing power of data; the rising impact of urbanisation on health; increasing patient centricity; the need for more flexible organisations and the move of innovation activity eastwards.
Available as both this report and as an accompanying presentation (https://www.slideshare.net/futureagenda2/future-of-healthcare-15-october-2019-182433390) this is now being used to inform and provoke further debate around the world. As ever we would like to thank all those who have given their time and insight to contribute to this project.
Held each year in Boston, Medical Informatics World connects more than 400 healthcare, biomedical science, health informatics, and IT leaders to navigate emerging trends and opportunities in the evolving industry. The event responds to the challenges in collaborating and maximizing the benefit of enabling technologies with inspiring plenary keynotes combined with focused expert-led presentations and discussions. Coverage includes population health management, predictive analytics, payer-provider-pharma data collaborations, patient care and engagement, mobile and wearable technologies, care delivery models, enterprise hospital information systems, clinical decision support, error and readmission reduction, and healthcare data security. The 2015 program features six conference tracks, two interactive dinner workshops and six plenary keynote presentations, providing attendees with the connections, tools and strategies for taking their research and care delivery to the next level. Learn more at http://www.medicalinformaticsworld.com
Top 10 fastest growing healthcare tech companies 2021insightscare
Ā
The document discusses Claimocity, an AI-driven healthcare technology company that provides mobile practice management software. It highlights some key points:
- Claimocity aims to streamline administrative and billing processes for doctors to allow them to focus on patient care.
- Their all-in-one software and services solution reduces multiple vendors and systems into a single integrated platform.
- Their progress note generator feature combines clinical documentation and billing documentation into a single mobile workflow.
- CEO Jim Sholeff has played a key role in the company's success through his leadership, product development expertise, and focus on specialized solutions for specific customer needs.
Value-based Healthcare - Towards a systems approach in chronic diseasesnDayOne
Ā
Role of patient journey in science, predictive modeling and high-risk patients in early stages of disease progression, in real world context. Presented by Michael Rebhan, Novartis at the DayOne Basel event in June 2020
Trends in Digital Health and why you should careMichael Weber
Ā
Driven by demographic change, rising costs in the healthcare system and growing customer demands for patient-centered tools, the relevance of innovative Digital Health solutions is constantly growing. While many technologies are available on the market, there is still a lack of comprehensive solutions that support the patient across all his medical conditions and provide an integrated user experience throughout the patient's everyday life. Future Digital Health solutions will not only have to cross-link patient data across different devices and applications in order to enable better medical decisions, but also to create user experiences that address the patients' needs and help them to establish self-sustaining behaviors towards a healthier lifestyle.
Evolution of the healthcare industry in India and the potential impact of the...Harshit Jain
Ā
2014 looks to be a positive but challenging year for the Indian health care sector; one in which many historic business models and operating processes will no longer suffice amid rising demand, continued cost pressures, lack of or inadequate care facilities, and rapidly evolving market conditions. India, likely will be dominated by the āModi-careā āHealth assurance for all.
UAEās 10 Best Healthcare Service Providers 2021 July 2021.insightscare
Ā
UAEās 10 Best Healthcare Service Providers 2021 features a few healthcare service providers that have been at the forefront of UAEās health care system.
El documento presenta una serie de juegos y ejercicios para evaluar la agilidad mental. Incluye actividades como encontrar letras escondidas, resolver problemas lĆ³gicos, contar elementos en un texto y determinar cuĆ”l de varias opciones es diferente. El objetivo es entretener al lector mientras pone a prueba su capacidad de razonamiento y percepciĆ³n.
This document provides an overview of the emerging Direct Primary Care (DPC) medical practice model. DPC charges monthly fees directly to patients, rather than billing insurance, in exchange for primary care services. The history of DPC is traced back to the late 1990s when some practices in Seattle began adopting this model. Key principles of DPC include a direct financial relationship with patients, increased time with providers, accessibility, and avoiding incentives of fee-for-service billing. The document examines several early DPC organizations, regulatory issues, perspectives of payers and consumers, and how technology supports the DPC model.
Healthcare Industry Taxonomy for the Population Health EraDave Chase
Ā
See https://www.linkedin.com/pulse/population-health-investments-catastrophically-misaligned-dave-chase for background on taxonomy
Created for The Future Health Ecosystem Today by Cascadia Capital and Dave Chase
The document outlines a strategy for transforming healthcare delivery and financing through a Health 3.0 model. Key elements include integrating pharmacy services into primary care, using health information exchanges and care coordination, implementing value-based payment models, promoting self care and wellness programs, creating a transparent medical marketplace, and addressing social determinants of health. The overall aim is to develop an accessible, affordable, and high-quality healthcare system.
The insights driving superior healthcare
outcomes in Asia Pacific.
Asia-Pacific Insight Magazine brings together IMS Health experts from across the region to engage in conversations about the forces that are shaping healthcare in Asia - and the strategies necessary to surge ahead of the competition
An introductory overview of healthcare across South East Asia and a look at the growing healthcare trends across the region.
Download the presentation by clicking the "Save this presentation" icon above.
An industry-wide survey of the health ecosystem. By looking at leading operating models that are representative of the future health ecosystem, the viewer can get a handle on how the future will look.
Powering the Future of Healthcare in Asia Pacific | Baker McKenzie | The Prop...Julien de Salaberry
Ā
This document discusses how technology will radically transform healthcare delivery in Asia Pacific. It notes that factors like Moore's Law, disruptive innovation, big data, genomics, wireless sensors, and other emerging technologies are driving a "creative destruction" and revolution in healthcare by enabling a shift to a more preventative, personalized model focused on outcomes rather than just treating diseases. The document argues that these technological changes provide an unprecedented opportunity for Asia Pacific countries to leapfrog traditional healthcare models and establish more effective, efficient systems tailored to their needs.
The document discusses 10 megatrends shaping healthcare and healthcare IT over the next 5-10 years based on a meta-analysis of several leading sources. The megatrends are organized into three groups: medicine, politics and society, and technology. Some of the key megatrends discussed include the rise of telemonitoring of patients, personalised medicine enabled by electronic health records, aging populations in western countries, increasing healthcare costs requiring value-based approaches, medical tourism and globalization, the growth of cloud computing and mobile technologies, and emerging fields like robotics and nanotechnology.
The document discusses several topics related to the future of healthcare, including:
1) How technology will continue to transform healthcare over the next decade through advances like artificial intelligence, digital technologies, and remote patient monitoring.
2) Key trends in the next 10 years including more patients, more technology, more information, and a shift to the patient as the ultimate consumer.
3) The roles of different healthcare professionals may change as technology advances, but nurses will still be needed to integrate data and apply their experience and skills.
4) Policies around healthcare access and coverage will also impact the future system, and replacement plans need to consider coverage for vulnerable groups.
mHealth Israel: PwC emerging mhealth paths for growthLevi Shapiro
Ā
Emerging mHealth holds great potential to improve healthcare access, costs and quality through ubiquitous mobile devices. However, widespread adoption faces challenges from healthcare's resistance to change and the need to navigate complex, fragmented systems. Expectations for mHealth are high among patients, doctors and payers, but most experts expect slower adoption as improving patient care often disrupts traditional models. Emerging markets are pioneering mHealth by leaping ahead through greater needs and fewer barriers, showing the path could be smoother where systems are less rigidly established.
American Healthcare Industrial RevolutionRobert Bond
Ā
Breakthroughs in information technology, telecommunications, and medical science have set the stage for a dramatic transformation of healthcare. The realities of large numbers of aging, chronically ill people will spark a crisis that will galvanize public opinion and lead to rapid change. Hereās what you should know regarding challenges and opportunities in the new landscape.
This document summarizes discussions from a series of events on technology ventures. It addresses 21st century paradigms for innovation, new innovation models, and focuses on digital technologies, biotechnology, and healthcare. Key topics discussed include using data and incentives to encourage preventative healthcare, balancing public and private use of health data, and how new firms are driving innovation in genomics and new drug discovery models through collaboration.
Future healthcare delivery will need to incorporate mHealth solutions due to changing demographic and economic factors. As populations age and healthcare costs rise, a shift towards preventative care and individual responsibility over one's health is needed. Mobile technologies can help enable this shift by providing remote patient monitoring, data collection for advanced diagnosis, and on-demand access to health information and services. Widespread adoption of mHealth still faces challenges around regulatory approval and data security that will require cooperation across the healthcare industry.
The Digital Medicine Crystal Ball: Unlocking the Future of Real-Time, Precise...Cris De Luca
Ā
The last five years have seen an unprecedented eruption in technological and health advances.
These new technologies and productsāmany undergoing rigorous clinical validationāwill have significant direct impacts on diagnosing, preventing, monitoring or treating a disease, condition or syndrome, which in turn will transform disease management and alter business models across industries.
This whitepaper describes the current and future influence of digital medicine on the health ecosystem and highlights how various stakeholders are working to deliver clinically impactful and economically viable solutions in a saturated yet still-emerging business environment.
Topics addressed in the whitepaper include:
How various stakeholders are working to deliver clinically impactful and economically viable solutions in a saturated yet still-emerging business environment
The new roles of traditional healthcare players
How the entrance of new technologies will affect partnership models and business strategies
The future of digital medicineās regulatory environment
Author: Nicole Fisher
The report, produced by EBD Group in collaboration with Hogan Lovells, and authored by Forbes contributor, Nicole Fisher, features insights from Christine Lemke, Evidation Health, Hogan Lovells, Cris De Luca, J&J Innovation, NIH/PMI, Rachel Sha, Sanofi, StartUp Health, and key opinion leaders such as John Nosta and Unity Stoakes.
mHealth Israel_ Digital Medicine_Whitepaper_The Digital Medicine Chrystal BallLevi Shapiro
Ā
The Digital Medicine Chrystal Ball: Unlocking the Future of Real-Time, Precise, Effective Healthcare. How will new digital technologies impact disease management and healthcare over the next decade? How will new digital technologies impact disease management and healthcare over the next decade?
Mobile health (mHealth) holds great promise to address issues in healthcare provision by leveraging ubiquitous mobile technologies. However, experts caution that widespread adoption of mHealth will be challenging and take time due to entrenched interests in existing systems and the need for disruptive changes. While patients, doctors and payers see benefits and inevitability of mHealth, most in the industry expect a period of hype, disillusionment, and slow progress as behaviors change and viable business models emerge. Further, adoption faces greater barriers in developed countries' complex systems compared to emerging markets with fewer obstacles but high demand for improved access to care.
Further to several additional expert workshops this year, we are delighted to share an updated global perspective on the future of healthcare. Produced in partnership with Duke Corporate Education (http://www.dukece.com), this adds new insights on the pivotal shifts taking place across the sector plus viewpoints on some of the core implications for leadership. Topics include the growing power of data; the rising impact of urbanisation on health; increasing patient centricity; the need for more flexible organisations and the move of innovation activity eastwards.
Available as both a report and as this accompanying presentation this is now being used to inform and provoke further debate around the world. As ever we would like to thank all those who have given their time and insight to contribute to this project.
Longevity industry landscape overview volume 1 - executive summaryApoorv Sharma
Ā
This document provides an overview of the longevity industry, including definitions of key concepts like geroscience, regenerative medicine, and rejuvenation biotechnology. It also summarizes trends like the aging global population, increasing baby boomer purchasing power, advances in gene therapy, cell therapy, and personalized/precision medicine. Major sections cover the scientific, regulatory, and investment landscapes of the longevity sector.
The document summarizes Steve Halasey's presentation at the 2010 Washington State Biomedical Device Summit on healthcare reform and the future of medical technology innovation. It provides an overview of InHealth, including its mission to fund research on the impacts of medical technology. It discusses InHealth's $11 million in research grants and $1 million+ in educational programs. It then analyzes the Patient Protection and Affordable Care Act and its potential unintended consequences for medical device manufacturers. It stresses the importance of evidence-based research and industry engagement to help shape new agencies and programs under healthcare reform.
GenSearch - Innovation in Healthcare: What is the Point?Alix Aubert
Ā
In this white paper, you will discover instances where innovation in technology and organisational operations are connecting patients to healthcare providers and are sharing secure clinical data with researchers. Others have disrupted traditional manufacturing methods to improve processes and some have even transformed organisational operations to create customer trust, value, and to improve outcomes for patients.
Moore's Law and The FUTURE of Health CareWayne Caswell
Ā
Moore's Law and exponential technological progress will significantly impact the future of healthcare. Sensors and computers will become smaller, cheaper, and more powerful, enabling constant health monitoring and personalized medical care. However, political and economic forces resisting change, like lobbying from profitable healthcare industries, may inhibit reforms needed to optimize healthcare systems for wellness and prevention over treatment of preventable diseases. Unless addressed, these economic and political challenges could prevent technologies from fulfilling their potential to transform healthcare for the better.
The 2019 edition of the Global Innovation Index (GII) focuses
on the theme Creating Healthy LivesāThe Future of Medical
Innovation. In the years to come, medical innovations such
as artificial intelligence (AI), genomics, and mobile health
applications will transform the delivery of healthcare in both
developed and emerging nations.
The key questions addressed in this edition of the GII include:
ā¢ What is the potential impact of medical innovation on
society and economic growth, and what obstacles must
be overcome to reach that potential?
ā¢ How is the global landscape for research and development
(R&D) and medical innovation changing?
ā¢ What health challenges do future innovations need to address
and what types of breakthroughs are on the horizon?
ā¢ What are the main opportunities and obstacles to future
medical innovation and what role might new policies play?
Make DNA data actionable - Festival of Genomics London 2018Omar Fogliadini
Ā
The document discusses the emerging field of genomic medicine and direct-to-consumer genetic testing. It notes that the cost of genome sequencing has dropped dramatically in recent years, enabling more people to access their genetic data. However, most doctors currently lack training in genomics and the implications of genetic testing. The development of genomic medicine will require greater integration of genetics into healthcare systems and medical education. The document also examines some of the challenges in ensuring patients and doctors can properly understand and act on genetic results.
The Pharma 2020 series
The Pharmaceutical industry's long successful strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for many years, but its R&D productivity has now plummeted and the environmentās changing. PwC believes that seven major trends are reshaping the marketplace:
Source of info:
http://www.pwc.com/gx/en/pharma-life-sciences/pharma2020/index.jhtml#
The document discusses the past, present, and future of the global health care industry. In the past 10 years (2003-2013), the industry advanced significantly through new technologies like MRI and CT scans. Financing also expanded from government to include private investors and institutions. Currently, the industry relies heavily on technology and sees continued growth in spending, especially in the US. The future expects further technological changes like health apps but also concerns over rising costs and reduced employment as technology replaces some jobs.
The document discusses how health care is likely to change over the next 20 years until 2040. Key points:
- Health care will be driven by digital transformation enabled by interoperable health data and artificial intelligence. The focus will shift from treating illness to sustaining well-being.
- By 2040, consumers will have highly detailed personal health data and will be at the center of their own health care decisions. Care will increasingly take place at home using remote monitoring technologies.
- Jobs in health care will change as monitoring health becomes continuous and focuses more on well-being rather than assessing and treating illness. Health systems will need to adapt to remain competitive against technology companies entering the space.
Similar to Powering the Future of Healthcare in Asia Ch.2 | The Propell Group | Baker & McKenzie (20)
Powering the Future of Healthcare in Asia - ETPL "IOT FOR HEALTH" PROGRAM | T...Julien de Salaberry
Ā
Presentation on the importance and impact of IoT Healthcare / Healthtech on the delivery of healthcare in Asia to the ETPL "IOT FOR HEALTH" PROGRAM cohort
#healthtechasia
X Sector Disruption | CIO Leaders Summit 2015 | The Propell GroupJulien de Salaberry
Ā
- Technology is or will disrupt your sector
- Hoping that it might miss you out is not a strategy!
- You will need to embrace and adopt the technology to innovate to stay in the game
- You also have the opportunity to explore how technology could enable your industry to disrupt another
Presentation given at the Garage Start Digital Health Startup Workshop sponsored by ABRT Venture Capital. Content focuses on the healthtech investment landscape.
This document summarizes key trends in global and Asian healthcare technology investment and mergers and acquisitions. Venture funding of healthtech doubled again in 2014 and outpaced other healthcare sectors. Top trends in healthtech funding from 2011-2014 included analytics/big data, digital medical devices, and telemedicine. There were over 95 M&A deals in healthtech in 2014 totaling $20 billion. Asia is an emerging market driven by factors like chronic disease management and senior healthcare. China, India, and Singapore have the most healthtech startups. Several Asian startups have raised millions in funding rounds.
- HealthTech innovation is disrupting healthcare and its established players
- Technology is driving a new paradigm to create better health care
- Developing markets can leapfrog their healthcare infrastructure limitations
- New opportunities are opening to shape the new paradigm
Healthcare, along with many other sectors, is facing increasing uncertainty driven by technology disruption and greater individual / patient empowerment. The barrier to entry into the sector is dropping fast enabling Asia entrepreneurs to significantly improve the Asia healthcare ecosystem
The healthcare industry is being disrupted by technology and a shift to greater patient / individual empowerment. This represents a formidable opportunity for healthcare in Asia. What catalyst role could / should strategics play in Asia healthcare innovation and how?
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
R3 Stem Cell Therapy: A New Hope for Women with Ovarian FailureR3 Stem Cell
Ā
Discover the groundbreaking advancements in stem cell therapy by R3 Stem Cell, offering new hope for women with ovarian failure. This innovative treatment aims to restore ovarian function, improve fertility, and enhance overall well-being, revolutionizing reproductive health for women worldwide.
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Ear Solutions (ESPL)
Ā
Binaural hearing using two hearing aids instead of one offers numerous advantages, including improved sound localization, enhanced sound quality, better speech understanding in noise, reduced listening effort, and greater overall satisfaction. By leveraging the brainās natural ability to process sound from both ears, binaural hearing aids provide a more balanced, clear, and comfortable hearing experience. If you or a loved one is considering hearing aids, consult with a hearing care professional at Ear Solutions hearing aid clinic in Mumbai to explore the benefits of binaural hearing and determine the best solution for your hearing needs. Embracing binaural hearing can lead to a richer, more engaging auditory experience and significantly improve your quality of life.
At Malayali Kerala Spa Ajman, Full Service includes individualized care for every client. We specifically design each massage session for the individual needs of the client. Our therapists are always willing to adjust the treatments based on the client's instruction and feedback. This guarantees that every client receives the treatment they expect.
By offering a variety of massage services, our Ajman Spa Massage Center can tackle physical, mental, and emotional illnesses. In addition, efficient identification of specific health conditions and designing treatment plans accordingly can significantly enhance the quality of massaging.
At Malayali Kerala Spa Ajman, we firmly believe that everyone should have the option to experience top-quality massage services regularly. To achieve that goal we offer cheap massage services in Ajman.
If you are interested in experiencing transformative massage treatment at Malayali Kerala Spa Ajman, you can use our Ajman Massage Center WhatsApp Number to schedule your next massage session.
Contact @ +971 529818279
Visit @ https://malayalikeralaspaajman.com/
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...rightmanforbloodline
Ā
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDr Rachana Gujar
Ā
Introduction: Substance use education is crucial due to its prevalence and societal impact.
Alcohol Use: Immediate and long-term risks include impaired judgment, health issues, and social consequences.
Tobacco Use: Immediate effects include increased heart rate, while long-term risks encompass cancer and heart disease.
Drug Use: Risks vary depending on the drug type, including health and psychological implications.
Prevention Strategies: Education, healthy coping mechanisms, community support, and policies are vital in preventing substance use.
Harm Reduction Strategies: Safe use practices, medication-assisted treatment, and naloxone availability aim to reduce harm.
Seeking Help for Addiction: Recognizing signs, available treatments, support systems, and resources are essential for recovery.
Personal Stories: Real stories of recovery emphasize hope and resilience.
Interactive Q&A: Engage the audience and encourage discussion.
Conclusion: Recap key points and emphasize the importance of awareness, prevention, and seeking help.
Resources: Provide contact information and links for further support.
MYASTHENIA GRAVIS POWER POINT PRESENTATIONblessyjannu21
Ā
Myasthenia gravis is a neurological disease. It affects the grave muscles in our body. Myasthenia gravis affects how the nerves communicate with the muscles. Drooping eyelids and/or double vision are often the first noticeable sign. It is involving the muscles controlling the eyes movement, facial expression, chewing and swallowing. It also effects the muscles neck and lip movement and respiration.
It is a neuromuscular disease characterized by abnormal weakness of voluntary muscles that improved with rest and the administration of anti-cholinesterase drugs.
The person may find difficult to stand, lift objects and speak or swallow. Medications and surgery can help the patient to relieve the symptoms of this lifelong illness.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
At Apollo Hospital, Lucknow, U.P., we provide specialized care for children experiencing dehydration and other symptoms. We also offer NICU & PICU Ambulance Facility Services. Consult our expert today for the best pediatric emergency care.
For More Details:
Map: https://cutt.ly/BwCeflYo
Name: Apollo Hospital
Address: Singar Nagar, LDA Colony, Lucknow, Uttar Pradesh 226012
Phone: 08429021957
Opening Hours: 24X7
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdfDr Rachana Gujar
Ā
The "Comprehensive Rainy Season Advisory: Safety and Preparedness Tips" offers essential guidance for navigating rainy weather conditions. It covers strategies for staying safe during storms, flood prevention measures, and advice on preparing for inclement weather. This advisory aims to ensure individuals are equipped with the knowledge and resources to handle the challenges of the rainy season effectively, emphasizing safety, preparedness, and resilience.
2. Powering the Future
of Healthcare in Asia Paciļ¬c
The HealthTech Report
NEXT ISSUE
Chapter
3
Funding
Data-driven
Healthcare
Chapter
2
Big Data and Analytics
Benefits
Legal Point of View:
Data-driven Healthcare
5 Ways Big Data is
Changing Healthcare
Legal Point of View:
Genomics
Legal Point of View:
Telemedicine
Biosensing Wearables
Mobile Devices Health
Legal Point of View:
mHealth
Legal Point of View:
Assessing Whether New
Technology is Subject to
Regulatory Compliance
Why have we commissioned
the report?
The Creative
Destruction
of Healthcare
Chapter
1
Mooreās Law
The Innovatorās
Dilemma
The Healthcare
Revolution
Dramatic Changes in
Healthcare: A Tectonic
Shift
Healthcareās New
Paradigm
What are the Legal
Consequences of the
Healthtech Revolution?
3. Key trends and innovation momentum
drivers in Asia Paciļ¬c healthcare
Preface
The delivery of healthcare is poised for a radical change.
The unparalleled ability to collect, mine and analyse health
data, the increasing sophistication of bio-sensors, and the
exponential rise in the use of smart phone devices provides
opportunities for a radical re-think in how to economically
and efficiently provide healthcare solutions for populations
across Asia Pacific. This will affect healthcare systems
providers as well as individuals. Healthcare resources that
have been constructed largely to treat disease will need
to be re-thought, to take advantage of technologies that
monitor to prevent illness and to intervene early.
Countries across the
region in various stages of
development are grappling
with the possibilities of
this healthtech revolution
and the legacy issues of
twentieth-century healthcare
infrastructure for twenty-
first-century healthcare
solutions. In doing so, many
issues are raised about the
use of new technologies in
healthcare that regulators
lag behind in answering. It is
these issues that we seek to
address.
This digital revolution of
medicine will not only
significantly benefit
developed health systems, but will also allow developing
economies to leapfrog over expensive development
stages to establish better, effective health systems. For
Asia Pacificās developing economies, following the same
evolutionary steps of developed economies is neither
feasible nor required. It will prove too costly, take too
long and lead to falling into the same pitfalls experienced
by developed health systems. Above all, it fails to take
advantage of the technology innovation that is disrupting the
delivery of healthcare.
The provision of modern-day healthcare across Asia Pacific
concerns all stakeholders such as physicians, patients,
hospitals, investors and ministries of health. The region
faces a considerable public health challenge which is
driving healthcare spending growth faster than GDP growth
and will continue to negatively impact productivity. By 2030,
India stands to lose approximately 18 million potentially
productive years of life due to non-communicable disease-
caused deaths.
Asia Pacific healthcare is a paradox of significant unmet
medical needs compounded by an under-invested and
immature health system infrastructure. It has a large
population that mostly pays for its own healthcare and is
experiencing fast-growing power of purchase, driving the
desire for greater choice and access to health services.
In this era of radical technological change and innovation,
the legal and regulatory landscape is undergoing gradual
transformation and harmonisation. The ASEAN Medical
Device Directive is an example of this. The healthcare
industry now faces the issue of ālaw lag,ā as laws are a
number of steps behind technological advances.
We are seeing common themes emerge across Asia Pacific
in legal developments, with a focus on data protection
laws, the regulation and promotion of medical devices,
and the ability to protect, enforce and commercialise
intellectual property. Governments and legislatures are
charged with the challenging task of balancing the need for
effective regulatory compliance with the need to foster and
accelerate innovation and development, as well as to reduce
overall healthcare costs.
The opportunity to power the future of healthcare in Asia
Pacific through technology innovation will transform the
delivery of better healthcare.
In these pages, we illustrate why we believe Asia Pacific
stakeholders have an unprecedented opportunity and we
propose how this could be achieved.
Ben McLaughlin
Head of Asia Pacific Healthcare Group
Baker & McKenzie
Julien de Salaberry
Founder and CIO
The Propell Group
4. The Creative
Destruction
of Healthcare
Chapter
1
Considered one of the most
inļ¬uential economists of the
twentieth century, Joseph
Schumpeter served as Austriaās
ļ¬nance minister and became a
professor at Harvard University.
In the mid-twentieth century,
Joseph Schumpeter, the
noted Austrian economist,
popularised the term
ācreative destructionā to
denote transformation
that accompanies radical
innovation. Over the past
few years, our lives have
been radically transformed
through digital and technology
innovation. But the most
precious part of our existenceā
our healthāhas thus far been
largely unaffectedāinsulated,
and almost separated from this
digital revolution. Until now.
Medicine is about to go
through its biggest
shakeup in history.
5. Asiaās developing economies
face a significant and growing
challenge to their ambitions
to build an OECD standard of
healthcare infrastructure and
delivery. Two main challenges
face these economies:
The prohibitive cost
of building such a
healthcare system
The increasing disease
burden ranging from
preventable communicable
diseases to the growing
trend in non-communicable
diseases brought on by
ageing and lifestyles
Asiaās policy makers must
therefore choose between
two options:
The conventional, long,
expensive and unsustainable
road which developed
economies have been
following
Taking full advantage of the
health technology innovations
and new operating models
which are transforming and
will continue to transform
healthcare across the globe
A founding father of Silicon
Valley, Gordon Moore co-founded
chipmaker Intel in 1968.
You can interpret the term
Mooreās Law in two ways. There is
its original meaning, which refers
to the speed at which transistors
on integrated circuits double.
Alternatively, you can use the
term as a metaphor to describe
any form of rapid technological
advancement. In its metaphorical
sense, Mooreās Law is now one
of the most important rules in
business and the economy today.
To borrow words used by
consultancy firm McKinsey:
Mooreās Law
Today, a human genome
can be sequenced in a few hours
and for a few thousand dollars,
a task that took 13 years
and $2.7 billion to accomplish
during the Human Genome Project.
Or to quote Craig Venterā
one of the leading scientists in
the world todayāin a lecture he
gave at the BBC in 2007:
The Innovatorās
Dilemma
First published in 1997,
Christensenās book suggests
that successful companies
can put too much emphasis on
customersā current needs, and
fail to adopt new technology or
business models that will meet
their unstated or future needs.
He argues that such companies
will eventually fall behind.
Christensen calls the anticipation
of future needs ādisruptive
innovation,ā and gives examples
such as the personal computer.
Harvard Business School
Professor Clayton Christensen
is the worldās authority on
disruptive innovation and
was named the Worldās Most
Inļ¬uential Business Management
Thinker in 2011 and 2013.
The innovatorās ādilemmaā comes
from the idea that organisations
will reject innovations based on
the fact that customers cannot
currently use them, thus allowing
these ideas with great potential
to go to waste.
Asia has a broad spectrum of
health systems and challenges,
with Myanmar at one end after
decades of under investment,
and Japan the opposite end of the
spectrum, with an OECD-standard
health system.
Whatever the level of maturity
of any Asian economyās health
system, we advocate that all of
Asiaās healthcare stakeholders
need to overcome their
innovatorās dilemma and take full
advantage of the technological
advances that are shaping
the new healthcare paradigm
powered by Mooreās Law.
Over a short period of time
genome projects, which,
10 years ago required
several years to complete,
now take only days.
He suggested that within half a
decade āit will be commonplace
to have your own genome
sequence, something that just
a decade ago required billions
of pounds and was considered a
monumental achievement.ā He
said, āOur ability to read genetic
code is changing even faster than
changes predicted by Mooreās
Law.ā
Metaphorical Mooreās Law may
yet prove to be even more extreme
in numerous medical disciplines
such as nanotechnology or
synthetic biology.
Two factors enabling
transformation
of healthcare
Factor 1
Factor 2
1
2
1
2
The innovatorās ādilemmaā
comes from the idea that
organisations will reject innovations
based on the fact that customers
cannot currently use them, thus
allowing these ideas with great
potential to go to waste.
6. CREATIVE
DESTRUCTION
MOOREāS LAW
1950S 1965
Popularised by Austrian
economist Joseph
Schumpeter, this refers
to the transformation
accompanying radical
innovation.
Intel founder Gordon
Mooreās observation
that computing speeds
double every two years,
an idea that can also be
applied to technology and
economics.
7. INNOVATORāS DILEMMA THE HEALTHCARE
REVOLUTION
Coined by Harvard
professor Clayton
Christensen, this refers
to companies rejecting
innovations based on
the fact that they cannot
currently be used, with
the ideas ending up going
to waste.
Dramatic changes of
medicine brought about
by mobile connectivity
and bandwidth, Internet,
social networking,
increasing computing
power and data universe,
information systems,
imaging, genomics and
wireless sensors.
1997 2015
8. The
Healthcare
Revolution
We are set to see a truly radical
change. Healthcare will focus on
prevention. Up to now, healthcare
has always concentrated on
diseases. We only tend to receive
medical attention if we are ill and
usually rely on symptoms to drive
us to seek a qualified medical
opinion. Technology will be used
to prevent us from becoming
sick. It will enhance us all in
ways that were once thought
to be the exclusive domain of
science fiction.
mobile connectivity
and bandwidth
social networkingInternet increasing computing
power and the data
universe
genomics wireless sensorsinformation systems imaging
Dramatic changes
in healthcareāa tectonic shift
Technologies that will create this
transformation include wearable
technology, genome sequencing,
collection, mining and analysis
of big data, 3-D printing,
nanotechnology, regenerative
medicine, bionic technologies,
and exoskeleton technology, to
name but a few. We will, however,
only consider the most relevant
to Asia Pacific in this report.
Nowadays, diseases that kill us
are rarely epidemics as medicine
has been very good at solving
these; instead, each one of us is
at risk of diseases of lifestyle,
e.g.,Type 2 diabetes (T2D). If
we could only make better
decisions about our lifestyle, we
could eliminate a substantial
number of deaths from modern
conditions. This is even more
applicable in an era where good
and comprehensive information is
available.
Technology is set to enable us to
make these decisions. It will also
enable us to enjoy better, more
customised care and live longer
in the future.
The creative destruction of
healthcare is being driven by
the convergence of the following
factors:
9. Data-driven
Healthcare
Chapter
2
Thomas Goetz, author of The
Decision Tree: Taking Control of
Your Health in the New Era of
Personalized Medicine, once said:
He is right. Data is of extreme
importance in the delivery of
a more efļ¬cient and effective
healthcare system, and healthcare
is becoming even more accessible
like never before in the history of
humanity.
Firstly, it can be small data,
speciļ¬c to an individual and used
solely to help people manage their
own health, or enable the doctor,
nurse or caregiver to support them
directly. Wearable technology and
advances in genome sequencing
are creating information that can
ensure that we apply healthcare
technology in the most effective
way.
Alternatively, it can be big data,
used by doctors, health insurers,
hospitals and governments in
the planning and execution of
healthcare.
We can use this data to diagnose
diseases more effectively,
implement superior preventive
healthcare, allocate resources
more efļ¬ciently and provide
statistics for epidemiological
analysis.
Big data is being made possible in
part by Mooreās Law, as computers
are able to process more and more
information. The cloud is emerging
as a massive repository of medical
data, which can be accessed
by doctors and other medical
professionals. Supercomputers,
such as IBMās Watson, are now
enabling deep analysis and
evidence-based reasoning for
more precise diagnosis and clinical
decision-making. IBMās Watson
is capable of reading millions
of unstructured papers in a few
seconds, which will enable it to
process patientsā electronic health
records, genomics, clinical data
and healthcare professionalsā
peer-reviewed publications. It is
also able to monitor real-time
data and new articles as they are
published.
Health insurers are using Watson
to speed pre-approval processes
for patients. Leading teaching
hospitals, such as Mayo Clinic in
the US, began working with IBM
Watson to improve medical school
training, in which they collaborate
to offer doctors real-time analysis
of patient records to improve care.
Mobile applications that allow
doctors and medical practitioners
to look up databases containing
information on thousands
of diseases, including signs,
symptoms and lab ļ¬ndings, are
now a reality. The physician often
has to make a diagnosis based on
patient responses to particular
questions and personal knowledge.
This cannot be inļ¬nite, resulting in
a need for additional data points.
These are usually laboratory tests
and/or second opinions from a
peer or a referral. In the future, the
access to a wealth of data, artiļ¬cial
intelligence (AI) analysis, as well as
peer to peer (P2P) will enable more
accurate diagnosis. For example,
uploading a photo of a skin rash
will generate a more accurate
diagnosis through comparison with
other patient cases and research
databases.
It wonāt be long before
technology breakthroughs such
as advanced voice recognition
are used in surgeries and other
medical procedures. MindMeld
has developed an application
that enables doctors or other
healthcare professionals such as
nurses to spend less time behind
their computers, encoding or
retrieving data from electronic
health records, thus allowing more
time to counsel their patients.
Combine this with apps that
support a doctorās diagnosis by
efļ¬ciently and quickly analysing
data from the big data cloud and
the patientās own sensors and
trackers, and the relevance and
accuracy of diagnosis will improve.
Data gives us information.
Information is vital in the war
against disease and in creating
a healthier society and a more
effective health system. But we
need technologies to implement
the ļ¬ndings of data.
Big Data and
Analytics
āHealthcare isnāt a
science problem, itās an
information problem.ā
Advances in computer
technology have created
major possibilities.
10. Just as the Internet of Things (IOT)
will provide data to transform
our homes, and just as big data
is revolutionising the world of
marketing, both are providing
mankind with the information
required to radically transform
healthcare.
It will provide doctors with the
tools for predictive analysis.
Natural language processing will
also turn the data into insights
about compliance and behaviour,
and doctors will take data from
individual departmental or
hospital silos and use it to gain
a much deeper insight into the
incidence of a particular disease.
Governments can plan better,
allocating resources according
to need and demand, and budget
more effectively. The result will
be signiļ¬cant. Singaporeās Smart
Nation Vision, which aims to
improve lives and businesses
through technology, comes to
mind. The initiative pulls together
world-ranked universities and
medical facilities, multi-billion-
dollar annual research and
development (R&D) investments,
a fast-growing community of
tech start-ups and large pools of
investment capital to bring about
better lives and greater business
opportunities. Health insurance
companies will be able to deļ¬ne
customised policies and premiums
according to individual risk proļ¬le.
Equally, consumers and patients
will gain greater visibility within
the complex health system, giving
them greater access to better-
suited and more affordable health
services. That empowerment will
eventually contribute to reducing
the enormous burden on essential
providers such as hospitals.
McKinseyās recent analysis of the
potential impact of known big
data and analytics advances on
US healthcare spending estimates
potential savings of up to USD450
billion.
Beneļ¬ts
The shift in the balance between
disease management and early
intervention will very likely have a
broad beneficial economic impact
on healthcare systems across the globe.
11. In the age of data-driven
healthcare, the ways in which
organisations can collect, store,
use and potentially disclose
personal or sensitive information
are growing exponentially. The
aggregation and analysis of this
data can have substantial economic
value to those who collect it, and as
we can see in the healthcare space,
even society beneļ¬ts if it is used
properly. Conversely, this push
towards data-driven healthcare
raises signiļ¬cant privacy concerns,
particularly where there is the
potential for an individualās
sensitive health information to be
disclosed (e.g., in the case of a
serious data breach).
The use of this sensitive
information is typically baselined
against the consent of the
individual to whom the data
relates, being obtained before it
is used for analytical purposes.
This consent requirement is not
necessarily complementary to the
vision of the beneļ¬ts ļ¬owing from
the use of big data in healthcare.
There are, however, some
examples of health information
being exempt from the privacy laws
for purposes relating to research
and development.
Data protection and privacy laws
across Asia Paciļ¬c regulate how
organisations use āpersonal
dataā or āpersonal informationā
identifying individuals. Most
businesses now collect, store,
use and potentially disclose
personal information in some
way. Asia Paciļ¬c has experienced
solid development in privacy
laws in recent times; however,
each country has its own
implementation and enforcement
systems.
Failure to comply, or responsibility
for a serious data breach, can
also damage an organisationās
reputation in the market and may
affect their standing with the
relevant government regulatory
body or agency.
There may also be speciļ¬c
laws or regulations that govern
the collection and handling of
individualsā health information.
There may be a legally enforceable
right for individuals to access their
health information contained in
records held by private and public
sector healthcare providers. The
application of these laws may
have a broader scope than the
regulation of āmedical devices,ā
and may apply to health and ļ¬tness
mobile apps, wearable devices
and associated software. These
requirements restrict the potential
beneļ¬ts ļ¬owing from the use of big
data in healthcare. However, there
are examples of carve-outs being
created for the collection and use
of big data for speciļ¬c purposes.
Some jurisdictions (such as
Singapore via the National Registry
of Diseases Act) regulate the
compilation of information relating
to certain diseases for use in
disease prevention. There may be
a duty for healthcare institutions
or practitioners who prescribe
medical devices to patients to
notify the relevant registrar of
reportable diseases (e.g., cancer).
Internal audit
As a company, you must
understand what personal data is
being collected and how it is being
used. In particular, the following
questions must be answered:
Legal Point of View:
Data-driven Healthcare
1. If you collect and use
personal information, have
you checked the regulatory
requirements on consent? If
you have collected the data
from an individual for one
purpose, but now seek to
use it for another, are you
required to seek āfreshā
consent from that individual?
1
2. Do you have appropriate
measures in place to
securely store personal
information and destroy or
de-identify this information
when it is no longer
required?
2
3. Does your company have a
privacy policy, and is it up to
date with your practices?
3
4. If you store personal
information offshore,
have you conducted a due
diligence-style assessment
of the privacy laws of the
recipient country?
4
5. Can you ensure that the
overseas recipient is also
bound by the same laws? Or
will you be liable if there is a
breach in that country, even
if it is completely out of your
control?
5
6. Are you able to negotiate
a data transfer agreement
with the recipient that
addresses matters such as
a data breach response and
notiļ¬cation plan?
6
7. Have you considered using a
data security ļ¬rm to assist
in protecting the integrity of
the personal information that
you store or use?
7
1. To what extent is personal
information or personal data
being collected? Examples of
personal information include
a patientās name, address,
medical records and bank
account details.
1
2. Is any āsensitiveā information
collected? Some jurisdictions
place strict requirements
on collection and use of
sensitive information,
including health information.
2
3. For what purpose is this
information collected?
The issue of consent by
individuals arises in multiple
jurisdictions. Where an
individual has consented
to the use of his personal
information for a purpose
(or multiple purposes), an
organisation should not use
that information for any
other purpose.
3
4. Is personal information
stored overseas? Some
jurisdictions include
restrictions on disclosing
or transferring personal
information outside of the
āhome jurisdiction.ā This is a
particularly important issue
for cloud service providers,
which often provide services
to customers in one country,
while basing their operations
in another.
4
Assessing compliance
Based on your answers to the
above questions, you must now
determine the extent of any data
protection compliance issues.
Remember, your company may
be held accountable for serious
data breaches involving personal
information.
The advantages of data-driven
healthcare are clear. However,
individuals and organisations
operating in the healthcare industries
must be aware that, as a general rule,
āhealth informationā is regarded
as sensitive and is more heavily
regulated under the various data
protection regimes.
It is imperative that big data
initiatives and products in
healthcare or otherwise comply with
data protection laws, as the
consequences of non-compliance
range from fines to criminal offences
and enforcement actions.
Privacy Concerns: Regulating
the Collection of Data
What are the key data protection
and privacy considerations for
big data in healthcare?
Case Example: Data Aggregators
in Healthcare
1. Are you required to notify
individuals when a data
breach occurs?
8
12. Human genome sequencing
provides scientists with a
roadmap of the human body. It is
probably easier to equate this to
understanding the computer code
that governs our body. Just as
computer code can contain bugs,
the human body equivalent would
be a defective protein, which would
leave it predisposed to a disease
such as cancer.
Advances in sequencing the
genome mean that in the next
ten years many rare diseases will
likely be downgraded to becoming
curable diseases. Healthcare
scientists agree that the genomic
breakthrough in cancer treatments
is already underway and
transforming the treatment of the
disease.
Genomics is becoming more
accessible and affordable through
technology advances. A process
that used to cost millions per
person now costs just a few
thousands. Novel business models,
which, for example, just focus on
a speciļ¬c therapy area such as
breast cancer, are able to provide
a service to women at a fraction of
the cost of a full DNA sequencing
procedure.
This new area of medicine will have
fundamental impact on how each
one of us will be able to manage
our health, starting with prevention
through disease management.
It will impact most stakeholders
from the patient to the healthcare
professional, drug discovery and
health insurance provider, to name
a few.
5 Ways Big Data is
Changing Healthcare
Genomics1
āChemotherapy is just medieval,ā
says Eric Topol, a leading American
cardiologist, geneticist and researcher.
āItās such a blunt instrument.
Weāre going to look back on it like
we do the dark ages. Tumours can
now be sequenced and drugs tailored
to the individual. Itās the dawn of
personalised medicine.ā
13. With groundbreaking developments
around the world in treating
and curing cancer and rare
diseases, genomics is elevated
above big data initiatives for its
transformative potential. However,
it is not without challenges both
from commercial and medical
perspectives. From a commercial
perspective, there is a need to have
adequate intellectual property right
(IPR) enforcement and protection
systems in place to protect genome
sequencing (via patent registration)
and, by extension, to encourage
R&D investment in this space.
Conversely, the medical
perspective can be a competing
consideration for genomics.
The very concept of obtaining
patent protection over human
genome sequencing and thereby
monopolising rights to methods
of medical treatment could be an
impediment to the full realisation
of genomicsā potential.
The Human Genome Project is a
practical example of the inherent
conļ¬ict between genomics and
intellectual property. The project
was designed to generate a
resource that would be freely
available in public databases
and used for a broad range of
biomedical studies. This is in
conļ¬ict with the very nature of
the legal monopoly granted by
patent protection. Equally, it is
clear that considerable time,
effort and funding are required
to translate discoveries in the
laboratory to treatment methods in
a medical clinic. Thus, patents are
an important way of encouraging
private funding in science, as they
allow investors the opportunity
to maximise the proļ¬t from their
investment.
The patentability of gene
sequences in developed IPR
governance systems such as
those in Australia, the USA and
Europe varies. In late 2015, the
Australian High Court determined
that nucleic acid isolated from
human cells was not patentable
subject matter under Australian
law (see DāArcy v Myriad Genetics
Inc. (2015) 325 ALR 100). This is
consistent with the position in the
USA where the US Supreme Court
ruled that naturally occurring
nucleic acid is a āproduct of
natureā and therefore cannot be
patented (see Association for
Molecular Pathology v. Myriad
Genetics Inc. 569 US - (2013)). In
Europe, however, there is no bar
to patenting gene sequences.
The European Union Directive
(98/44/EC) expressly provides
that biological material (including
gene sequences) can be patented
provided the gene sequence
is useful (i.e., susceptible to
industrial application) and this is
disclosed in the patent application.
While patenting gene sequences or
naturally occurring isolated nucleic
acids per se is not permitted in
Australia, the patentability of
gene-related inventions remains
possible. In Myriad, the High Court
of Australia expressly left open the
possibility that, where there is a
new or improved process of nucleic
acid isolation or where an invention
consists of the application of
isolated nucleic acid to a particular
use, that method of isolation or use
may be patentable.
Legal Point of View:
Genomics
14. Legal Point of View:
Telemedicine
The increasing use and availability
of telemedicine (or telehealth) is an
important example of how big data
is changing the face of healthcare.
Telemedicine refers to the
systematic provision of healthcare
services over physically separate
environments via an electronic
communications network. This
exchange of healthcare information
between patients and healthcare
providers (for diagnostic and
clinical purposes) can be over the
telephone, through text messaging,
email, smart phone application
or other telecommunications
technology.
Telemedicine has been used in
Asia Paciļ¬c for close to a decade,
and the regulatory environment is
ļ¬nally catching up. For example,
in Singapore, new National
Telemedicine Guidelines (NTG),
covering a wide scope of services,
were recently issued by the
Singapore Ministry of Health.
The NTG distinguishes between
healthcare organisations and
healthcare professionals involved
in the provision of telemedicine and
imposes different obligations on
each group.
From a legal perspective, the
development of telemedicine as a
viable method of providing medical
services raises various regulatory
issues. For example, in the future,
will we see telecommunication/
Internet service provider (ISP)
companies face liability for
failing to adequately facilitate
these services? Or will the
telecommunications industry
also be required to comply with
laws regulating the provision of
therapeutic services?
Given the potential for vast
amounts of personal and/or
sensitive health information
to be transferred using
telecommunications technology,
telemedicine also raises concerns
in relation to privacy and data
protection. As with conventional
medicine, a clinician practicing
in telemedicine has the same
duties to safeguard a patientās
medical records and maintain
conļ¬dentiality. However, the
unique challenge for telemedicine
clinicians is to manage the
increasing number of people
who will potentially have access
to a patientās records and to
ensure that protocols are strictly
followed to ensure the integrity of
data and images transmitted for
the purposes of a telemedicine
consultation.
However, telemedicine raises
several legal issues, such as data
privacy and licensing for cross-
border services, that each jurisdiction
must confront and develop a
framework for.
15. 2 Data Analytics
Healthcare data analytics
makes extensive use of data,
statistical and qualitative analysis,
explanatory and predictive
modelling. It is the process of
working with and mixing data
sets so as to transform data into
useful insights to support decision-
making.
This is being compounded by rapid
growth of data with some 90% of
the data available today having
been created in the last two years
alone, according to IBM.
Digitising the ļ¬les from the
hospitalsā or physiciansā notes is
the core of the electronic health
(or medical) record (a.k.a. EHR
or EMR). The ideal EHR would
be a comprehensive ļ¬le that
includes all laboratory data as
well as reports from procedures,
operations, diagnostic tests,
hospital discharges and visits with
all healthcare practitioners. The
launch of smart phone applications
will allow the patient to have their
own personal health record (PHR),
which would ensure it is accessible
everywhere or when needed.
Initiatives in the US to digitise
these records have delivered
impressive results such as a 41%
reduction in error rate and a 51%
reduction of adverse drug events in
just one hospital.
If we consider the enormous
burden placed on hospitals in most
countries across the world, using
big data and predictive analytics
tools will provide much needed
decision support tools to reduce
cost, improve the quality of care
and improve outcomes through
smart operational improvements
in hospitals through focus on the
following:
1. Reducing readmissions by
identifying high-risk patients
and readmission time
2. Workforce planning for
optimal nurse scheduling
3. Maximising hospital
resources such as bed and
operating rooms
4. Optimising elective
admissions schedules to
reduce midweek congestion
and bed block
5. Scheduling operating rooms
efļ¬ciently to coordinate
patient care paths
1
2
3
4
5
The single greatest challenge
facing healthcare data analytics is
fragmentation of the available data.
16. 3 Public Awareness: Planning & Preventing
One of the biggest causes of
disease in developing economies is
a lack of awareness of the diseases
(both communicable and non-
communicable) and their causes.
For example, diabetes prevalence
in India is as high as 10% of the
population (WHO) but fewer than
1% seek counsel from a healthcare
professional. Often enough,
they seek consultation once the
symptoms are quite advanced.
Current costs prevent routine
health checks for the majority
of the population in developing
economies.
Mobile device penetration is
extremely high in Asia, facilitating
both push-and-pull health and
wellness information to be
communicated or exchanged.
In many Asian economies, the
presence of counterfeit medicine
further reduces the effectiveness
of the healthcare system. For
example, up to 50% of anti-
malarial drugs in Cambodia are
fake, leading to many patients
being poisoned. Mobile devices
provide a simple solution to
verifying the authenticity of the
medicine being purchased similar
to countering credit card fraud.
The use of mobile technology
in collaboration with a well-thought-
through disease awareness
campaign would enable the effective
use of data to reduce and prevent
disease.
17. 4
The power of todayās computers
combined with the major advances
in analytics, such as machine
learning, is making it possible to
blend a greater variety of data to
generate clinical and non-clinical
intelligence.
IBMās Watson supercomputer
has the capability to analyse vast
amounts of data on a cloud-based
platform that puts the power
of the analysis in the hands of
physicians, researchers, insurance
actuaries and other non-technical
users. Using advanced technical
capabilities, such as artiļ¬cial
intelligence and machine learning
algorithms, the system responds to
clinical queries in natural language
and comes up with responses
based on medical evidence that is
gathered and constantly analysed
in the system.
In May 2015, IBM Watson Health
announced a major push into
the healthcare analytics space
through strategic partnerships
with Mayo Clinic, one of the leading
hospitals and medical research
institutions in the US, and Epic,
a provider of Electronic Health
Record (EHR) systems with access
to vast amounts of patient medical
records. IBM has been aggressively
pursuing access to patient data
to feed the Watson engine, more
recently through the acquisition
of Explorys and Phytel. These
acquisitions and partnerships
deepen IBMās commitment
to extend Watsonās cognitive
computing power to advance the
quality of healthcare, speciļ¬cally
in areas such as cancer prediction
and treatment.
Similarly, new entrants in
healthcare such as Google or
Flatiron Health are focused on
linking and analysing all the patient
and research data of a speciļ¬c
disease area such as oncology to
develop insights to signiļ¬cantly
improve research and treatment.
Support Providers
18. 5 Support Self-Care/Digital Therapeutics
The rapidly expanding ownership
of smart devices (over 1 billion
Android devices worldwide)
equipped with a growing number
of built-in sensors and the growing
versatility of wearables (which
we discuss in the next section)
are making patient-empowered
disease and pre-disease
management a reality through the
combination of customised apps
and the increasing variety and
frequency of patient-centric data.
In the past few years, a handful
of medically minded visionaries
have put real clinical rigor into
every aspect of their disease
management application design.
For instance, David Van Sickle,
a former CDC epidemiologist
intelligence ofļ¬cer, and now the
CEO and co-founder of Propeller
Health, built a GPS-enabled sensor
for asthma inhalers that links to
a mobile device app ā every puff
is mapped and time-stamped,
allowing patients and doctors to
spot patterns in ārandomā attacks
and identify previously unknown
triggers.
For the ļ¬rst time in its history,
the World Health Organizationās
Centers for Disease Control and
Prevention (CDC) has recognised
digital therapeutics as meeting
the evidence-based standards for
the agencyās National Diabetes
Prevention Program (DPP) when
it listed Omada Health as an
effective diabetes management
aid in March 2015.
We will likely see physicians
prescribing regulation-approved
apps not just to monitor and
manage chronic disease but also
to pre-empt acute disease events.
Preventing individuals from
progressing to more advanced
diabetes status through device-
based therapies or behavioural
change would have a signiļ¬cant
impact.
We should also consider the
beneļ¬cial impact of this type of
technology on improving disease
awareness in a region where a
small fraction of individuals at risk
or with a chronic disease actually
consult a healthcare professional.
The high prevalence of chronic
diseases in Asia warrants the need
for similar behavioural change
digital programs customised
to be appropriate to differing levels
of income and device sophistication,
among others.
19. First-generation consumer
wearables were built with just one
sensor (accelerometer), and they
are already making a difference.
Wearable devices from Fitbit or
Jawbone can, for example, tell us
how active we are in a day, or a
week or a month. They can also
estimate the quality of our sleep.
More to the point, such products
encourage us to improve our
habits and/or behaviour through
gamiļ¬cation. This can involve
incentivising and rewarding
people to meet pre-set goals
using techniques often used in
games, for example, rewards, or
a progress bar, in addition to peer
pressure via social media.
Next-generation wearable
biosensors such as smart
watches, smart clothing, jewelry,
patches and wearable tattoos
are emerging and are able to
capture physiological data such as
movement, respiration, hydration,
glucose, skin conductivity, heart
rate, temperature, posture, oxygen
level, muscle activity and blood
pressure.
Next-generation wearable
biosensor technologies will be
embedded in our clothes, homes
and cars, and other places we
regularly frequent or use.
Biosensing
Wearables
Biosensors
Devices that convert a
biological element into
a signal output
Activity
Trackers
e.g., Fitbit, Misļ¬t
Smart
Watches
e.g., Garmin
Patches and
Tattoos
e.g., Zio, MC10
Smart
Clothing
e.g., Athos
Ingestibles and
Smart Implants
e.g., Proteus
Wearables
On- or in-body devices
that enable user
experience
Chronic diseases, such as
diabetes, can also be better self-
managed with apps, in tandem
with speciļ¬c wearable biosensors
such as a glucose meter that helps
to measure carb intake, calculate
administered insulin quantity and
receive tips on diet and lifestyle
modiļ¬cations essential for slowing
down the progress of the disease.
The combination of biosensors
and advanced data analytics is
rapidly democratising the access
to personal health data as well as
access to complex computational
capability and placing it in peopleās
hands. They are effectively
transferring power from the hands
of scientists and academics to
ordinary citizens.
A very similar revolution is taking
place in the medical device
environment. Take for example
AliveCor, a peripheral attached to
a smart phone that enables users
to record and share their own
electrocardiograms (ECG/EKG).
Amongst other things, this device
will probably spell the demise of
the stethoscope. Doctors prescribe
the device for at-home use so that
they can regularly monitor patients
remotely. Today, if patients do
not have the symptoms of heart
disease it is generally assumed
that they donāt have the disease.
Home use would enable a doctor
to track whether a patientās at-
rest heart rate is rising over a
prolonged period of time and
therefore tackle potential heart
disease early. This way, patients
can also determine whether the
therapy they have been prescribed
is effective.
Imagine slapping a sticker on
your arm that could measure a
wide array of medical indicators
ā heart rate, body temperature,
blood pressure and more ā and
transmitting that data wirelessly
to your smartphone. MC10 is
developing products that can be
used both on and inside the body,
that monitor head impact, heart
rate, brain activity, muscle function,
body temperature and hydration.
It is also developing an entirely
new class of intelligent medical
device with embedded sensors for
enhanced sensing and therapeutic
capabilities. Looking forward a
few more years, combine this with
advances in nanotechnology, and
the same sticker will also be able
to release drugs stored inside
nanoparticles when data from the
sensors suggest it is required.
This technology will fundamentally
change the way in which medicine
is administered and how chronic
diseases such as Parkinsonās are
managed.
We have deliberately not addressed
other signiļ¬cant scientiļ¬c
advances such as regenerative
medicine, stem cell research and
nanotechnology, as these are
regarded to not be sufļ¬ciently
advanced to have an impact on
Asiaās health system in the short to
medium term.
Thanks to advances in the
computing power of handheld
devices, combined with an
increasing number of sensors
built into them, it is becoming both
practical and realistic for patients
to manage their own healthcare in a
way that was never possible before.
What data privacy and compliance
issues arise from biosensing
wearables?
20. Mobile Devices
Health
Recently published research
estimates mobile phone
penetration in Asia Paciļ¬c to reach
70% of the population by 2019. This
will continue to grow as countries
such as Myanmar build their
mobile phone network and their
population comes online. Smart
phone adoption is also growing fast
as new handset manufacturers
(e.g., Xiaomi in China or Micromax
in India) enter the market with
state-of-the-art devices for
USD250 or less.
Tablet ownership has also recorded
signiļ¬cant growth in many Asia
Paciļ¬c countries.
As Thomas Goetz put it, healthcare
is about information. We are
all looking for data to inform
our personal and professional
decisions, e.g., shopping, dining
out and booking taxis. Delivering
better healthcare in Asia Paciļ¬c
should be no different. Mobile
devices enable this by giving the
health system the ability to do the
following:
1. Provide health information
and education
2. Communicate broadly and
directly with the population
on health matters
3. Engage directly with the
population on health matters
related to them
It has the power to break down the
barrier between healthcare and the
consumer/patient-democratising
healthcare.
A poignant example of its impact
relates to infant mortality in the
region. Countries such as India
and Indonesia have failed to meet
their United Nations Millenium
Development Goal (MDG) to
reduce infant mortality. The infant
mortality rate in India is three
times higher than Chinaās and
seven times greater than that
of the US. There are numerous
causes of infant mortality, but
an important one is insufļ¬cient
maternal health.
A leading consumer goods
manufacturer launched a program
that works with mothers and
community leaders to educate
them on basic health practices
such as washing hands with soap
daily, particularly before handling
newborn infants.
This very successful program
provided mothers of newborn
infants with free-of-charge
awareness and education modules
via their mobile phones speciļ¬cally
designed to address rural areas
where most handsets are still
unsophisticated. The company also
adjusted its soap pack size to cater
to the daily cash ļ¬ow limitations
that exist in rural areas.
Overall mothers and infants have
beneļ¬ted and the consumer goods
company has generated revenue
and brand awareness with a new
customer segment. It is a great
template for other healthcare
stakeholders as we aim to improve
healthcare in the lower echelons of
the income pyramid.
1
2
3
21. Mobile health, now known as
āmHealth,ā has been identiļ¬ed
by the World Health Organization
as having āthe potential to
transform the face of health
service delivery across the globe.ā
The rise in the use of mHealth
in developing countries presents
signiļ¬cant risks in countries where
privacy laws are non-existent or
inconsistent. To address these
risks, Baker & McKenzie and
Merck partnered with the United
Nations Foundationās mHealth
Alliance and the Thomson Reuters
Foundationās TrustLaw to develop
āPatient Privacy in a Mobile World:
A Framework to Address Privacy
Law Issues in Mobile Healthā (June
2013). This pioneering initiative
covers mHealth-related privacy
and security issues around the
globe.
A key purpose of the mHealth
Alliance Report was to review
privacy and security policies
around the world and to identify
gaps in these policies that must
be addressed to protect personal
health information. The mHealth
Framework states that privacy
laws are roughly split among (1)
omnibus data protection (i.e.,
laws that regulate all personal
information, as in Europe), (2)
sectoral privacy laws that address
privacy issues in speciļ¬c industries
and business sectors (as in
the US), and (3) constitutional
protections, where there is a
human right to the protection of
personal information.
The mHealth Framework sets
out a functional framework for
addressing these privacy law
gaps, and is sensitive to different
cultural, technological and
institutional contexts.
Legal Point of View:
mHealth
Notably, the results of the mHealth
Framework indicate that few existing
laws make reference to mHealth or
other technological advances in
healthcare.
22. The development of applications
assisting in the diagnosis and
treatment of medical conditions
can give rise to regulatory
requirements. In particular,
some jurisdictions have provided
guidance that mobile apps with
therapeutic application, or
marketed as having therapeutic
application, could be regarded
as āmedical devicesā under the
applicable regulatory regimes.
Is it a āmedical deviceā?
Several jurisdictions in Asia Paciļ¬c
have extended the deļ¬nition
of āmedical deviceā to capture
a large number of healthcare
technologies, including smart
phone applications, blood pressure
monitors, diagnostic software
and disposable cell testing
devices. In some instances, these
technologies may need to be
registered with a government
body or agency before they can
be imported, exported or made
available in the market.
Generally, medical devices will
be any article or object (including
software) that is intended to
diagnose, prevent, monitor or treat
a disease or injury in humans.
Some countries, such as Malaysia,
require all medical devices to be
registered with the Ministry of
Health, while other countries, such
as Australia, may take a ārisk-
basedā approach to regulation. This
means that the level of scrutiny
and oversight by the government
body or agency will vary according
to the level of risk that the product
represents to the patient or
physician using it.
In some cases, whether a product
is considered to be a āmedical
deviceā will depend on (a) the
intention of the manufacturer or
supplier, and/or (b) how they will
market (or have marketed) their
product. We see this illustrated in
the treatment of wearable devices
and other devices developed for
use in relation to āquantiļ¬ed selfā
health information by different
regulatory regimes across Asia
Paciļ¬c. In some jurisdictions,
devices marketed as being used
for sporting activities are exempt
from regulation; however, a
largely similar device, which was
marketed as having more general
application, may not be able to
take advantage of this exemption
and could therefore be subject to
regulation (despite having similar
or identical functionality).
In contrast, in jurisdictions such
as Australia that regulate devices
having therapeutic application,
a device may be subject to
regulation if it is marketed as
having a purpose relating to
diagnosis, prevention, monitoring,
treatment or alleviation of disease,
for example. If the device is not
marketed this way, it will not
be regulated. In late 2014, the
Australian regulator clariļ¬ed that
the deļ¬nition of a medical device
includes āsoftware programs or
operating instructions that control
the functioning of an electronic
device such as smart phone
apps.ā The key consideration is
whether the app simply presents
information to users (in which
case it is unlikely to be a medical
device) or whether the app has a
therapeutic or diagnostic use, for
example, by way of a monitoring
or diagnostic function (in which
case it is likely to be classiļ¬ed as a
medical device).
However, an app regulated as a
medical device in its own right and
developed for use in conjunction
with an unregulated wearable or
quantiļ¬ed-self device is unlikely
to extend regulation to the device
and is likely to be seen by the
regulator as extending ābeyond the
intended useā of the manufacturer,
and therefore the device itself can
still be treated as a consumer
electronic device and not a medical
device.
Promotion, advertising and
other marketing of medical and
healthcare technologies is closely
scrutinised in most jurisdictions
to protect patients, consumers
and healthcare professionals.
Generally, most countries in
Asia Paciļ¬c will prohibit any
commercial conduct that is
misleading or deceptive, in addition
to speciļ¬c prohibitions relating to
the healthcare industries.
1. In Australia, the Therapeutic
Goods Advertising Code
2007 regulates the
advertising and promotion
of certain therapeutic
goods, including āmedical
devices,ā and contains a
number of prohibitions and
requirements.
2. In China, the Advertising
Law (administered by the
State Administration for
Industry and Commerce)
provides that advertisements
published through the
mass media should be
marked as such, and be
differentiated from other
non-advertising information,
so that consumers are
not confused or misled.
The Advertising Law also
requires all advertisements
containing drug names and
the ailment or symptoms to
undergo examination before
publication.
3. In Hong Kong, the
Undesirable Medical
Advertisements Ordinance
(Cap 231) restricts the
advertising of abortion,
medicines, surgical
equipment and treatment for
curing or preventing certain
diseases or conditions.
āMedical devicesā will often be
subject to the same legislation as
medicinal or other therapeutic
products. However, the speciļ¬c
prohibitions on advertising of
medicine (particularly prescription
medicine) to healthcare
professionals and consumers
generally will not extend to
medical devices. For example, a
requirement that advertisements
for prescription medicines be
pre-approved by the government
agency may not apply for medical
devices. However, this differs
between jurisdictions, and one
must carefully review applicable
advertising laws and codes before
commercialising a product. Some
countries, such as Japan, even
allow advertising of prescription
medicines on television direct
to consumers, provided such
advertising is not misleading
and encourages responsible
consumption.
Be aware that in some cases,
the advertising codes may be
developed and published by
industry bodies (such as the
Medical Technology Association of
Australia), which do not have any
formal regulatory function but can
be either binding upon members or
set the baseline for best practice in
that jurisdiction.
3
Legal Point of View:
Assessing Whether New
Technology is Subject to
Regulatory Compliance
Therefore, when dealing with any
medtech product, the key question
to ask is, is the product considered
to be a āmedical deviceā in this
jurisdiction?
1
2
Promotion
23. Baker & McKenzieās Asia Pacific Healthcare Group
has advised global pharmaceutical, life sciences and
medical devices companies for more than 50 years.
The Firm ranked Band 1 in the Chambers Asia Pacific
Life Sciences rankings for two consecutive years
(2014-2015). In Asia Pacific, Baker & McKenzie has
more than 150 lawyers, more than 20 of whom have
healthcare and medical-related qualifications, as well
as a number of non-lawyer medical practitioners who
hold doctorate degrees in fields such as biotechnology,
pharmacology, nursing and bioethics. Our team has
a thorough appreciation of issues facing our clients,
from compliance pressures and complex pricing and
reimbursement difficulties, to red-flag issues such as
anti-corruption.
As a trusted advisor to the worldās largest life sciences
companies, the Baker & McKenzie Asia Pacific
Healthcare Group offers cutting-edge value-added
services to help clients stay abreast of key industry
trends.
These products include the following:
Webinars
Client seminars
Publications such as From Pills to Tablets and
Investing in the Healthcare Industry
Mobile apps such as the MapApp, which won
the Innovative Use of Technology Award at the
FT Innovative Lawyers Asia Pacific Awards 2015
(download it on the App Store)
Thought leadership reports (example: Powering the
Future of Healthcare in Asia Pacific)
Ben McLaughlin
Head, Asia Pacific Healthcare Group
ben.mclaughlin@bakermckenzie.com
About the Asia Pacific
Healthcare Group
Ben McLaughlin talks about
Baker & McKenzieās strengths
and value-added client services
24. Contributors
Ben McLaughlin
Head, Asia Pacific Healthcare Group
Baker & McKenzie
Sydney
Tel: +61 2 8922 5342
Ben.McLaughlin@bakermckenzie.com
View CV
Julien de Salaberry
Founder and CIO, The Propell Group
Singapore
Tel: +65 9488 7334
julien@propellgroup.biz
View CV
Yee Chung Seck
Partner, Baker & McKenzie
Ho Chi Minh City
Tel: +84 8 3520 2633
YeeChung.Seck@bakermckenzie.com
View CV
Toby Patten
Special Counsel, Baker & McKenzie
Melbourne
Tel: +61 3 9617 4456
Toby.Patten@bakermckenzie.com
View CV
Anne-Marie Allgrove
Partner, Baker & McKenzie
Sydney
Tel: +61 2 8922 5274
Anne-marie.Allgrove@bakermckenzie.com
View CV
Andy Leck
Principal, Baker & McKenzie.Wong & Leow
Singapore
Tel: +65 6434 2525
Andy.Leck@bakermckenzie.com
View CV
Ren Jun Lim
Local Principal, Baker & McKenzie.Wong & Leow
Singapore
Tel: +65 6434 2721
Ren.Jun.Lim@bakermckenzie.com
James Halliday
Partner, Baker & McKenzie
Sydney
Tel: +61 2 8922 5187
James.Halliday@bakermckenzie.com
View CV
Elisabeth White
Partner, Baker & McKenzie
Sydney
Tel: +61 2 8922 5386
Elisabeth.White@bakermckenzie.com
View CV
Monique Nicolle
Senior Associate, Baker & McKenzie
Sydney
Rebekah Lam
Associate, Baker & McKenzie
Sydney
Grace Loukides
Graduate at Law, Baker & McKenzie
Melbourne
Le Thu Minh
Legal Assistant, Baker & McKenzie
Ho Chi Minh City
Rosaline Chow Koo
Founder and CEO, CXA Group
Singapore
Kae Yuan Tan
Co-founder and CEO, REKA Health
Singapore
Francois Cadiou
Co-founder and CEO, Healint
Singapore